An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes

Neuroscience Applied 2026 Open access

Read full text

Authors: N. Mcgowan, James Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G M Goodwin

DOI: 10.1016/j.nsa.2025.106821

Cited by: 0

Fields of Study & Subjects

Psychedelics and Drug Studies Pain Management and Placebo Effect Digital Mental Health Interventions